KEGG   DRUG: Oblimersen
Entry
D08290                      Drug                                   

Name
Oblimersen (INN)
Formula
C172H221N62O91P17S17
Exact mass
5680.5363
Mol weight
5684.6149
Remark
ATC code: L01XX36
Chemical structure group: DG00728
Efficacy
Antineoplastic, Translation inhibitor, Bcl-2 inhibitor
Comment
Antisense oligonucleotide
Cytostatic, cytostaticum
Target
BCL2 [HSA:596] [KO:K02161] (mRNA)
  Pathway
hsa04210  Apoptosis
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L01 ANTINEOPLASTIC AGENTS
   L01X OTHER ANTINEOPLASTIC AGENTS
    L01XX Other antineoplastic agents
     L01XX36 Oblimersen
      D08290  Oblimersen (INN)
Target-based classification of drugs [BR:br08310]
 Not elsewhere classified
  Cellular process
   Apoptosis
    BCL2
     D08290  Oblimersen (INN)
Other DBs
PubChem: 96024977
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system